155 related articles for article (PubMed ID: 27174092)
41. Increased ratio of FoxP3+ regulatory T cells/CD3+ T cells in skin lesions in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms.
Morito H; Ogawa K; Fukumoto T; Kobayashi N; Morii T; Kasai T; Nonomura A; Kishimoto T; Asada H
Clin Exp Dermatol; 2014 Apr; 39(3):284-91. PubMed ID: 24635062
[TBL] [Abstract][Full Text] [Related]
42. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response.
Picard D; Janela B; Descamps V; D'Incan M; Courville P; Jacquot S; Rogez S; Mardivirin L; Moins-Teisserenc H; Toubert A; Benichou J; Joly P; Musette P
Sci Transl Med; 2010 Aug; 2(46):46ra62. PubMed ID: 20739682
[TBL] [Abstract][Full Text] [Related]
43. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
[TBL] [Abstract][Full Text] [Related]
44. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
45. Flowcytometric study of expression of perforin and CD134 in patients with systemic lupus erythematosus.
Abo-Elenein A; Shaaban D; Gheith O
Egypt J Immunol; 2008; 15(2):135-43. PubMed ID: 20306696
[TBL] [Abstract][Full Text] [Related]
46. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution.
Ushigome Y; Kano Y; Ishida T; Hirahara K; Shiohara T
J Am Acad Dermatol; 2013 May; 68(5):721-8. PubMed ID: 23182063
[TBL] [Abstract][Full Text] [Related]
47. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019.
Shiohara T; Mizukawa Y
Allergol Int; 2019 Jul; 68(3):301-308. PubMed ID: 31000444
[TBL] [Abstract][Full Text] [Related]
48. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y
J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366
[TBL] [Abstract][Full Text] [Related]
49. Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines.
Korekawa A; Nakajima K; Fukushi K; Nakano H; Sawamura D
J Dermatol; 2022 Jun; 49(6):652-655. PubMed ID: 35243679
[TBL] [Abstract][Full Text] [Related]
50. Association of CD8(+) T lymphocyte repertoire spreading with the severity of DRESS syndrome.
Niu J; Jia Q; Ni Q; Yang Y; Chen G; Yang X; Zhai Z; Yu H; Guan P; Lin R; Song Z; Li QJ; Hao F; Zhong H; Wan Y
Sci Rep; 2015 Apr; 5():9913. PubMed ID: 25905582
[TBL] [Abstract][Full Text] [Related]
51. Thiol levels in CD134-defined subsets of rat T lymphocytes: possible implications for HgCl2-induced immune dysregulation.
Roos A; Claessen N; Schilder-Tol EJ; Chand MA; Weening JJ; Aten J
Biochem Biophys Res Commun; 1997 Nov; 240(2):452-7. PubMed ID: 9388500
[TBL] [Abstract][Full Text] [Related]
52. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.
Dumitriu IE; Baruah P; Finlayson CJ; Loftus IM; Antunes RF; Lim P; Bunce N; Kaski JC
Circ Res; 2012 Mar; 110(6):857-69. PubMed ID: 22282196
[TBL] [Abstract][Full Text] [Related]
53. Pathological findings of lymphadenopathy in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic syndrome (DRESS): similarities with angioimmunoblastic T-cell lymphoma.
Sato R; Itoh M; Suzuki H; Kusuhara Y; Nakayama M; Kikuchi S; Tanito K; Nakagawa H
Eur J Dermatol; 2017 Apr; 27(2):201-202. PubMed ID: 28120775
[No Abstract] [Full Text] [Related]
54. Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome.
Morita C; Yanase T; Shiohara T; Aoyama Y
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30368475
[TBL] [Abstract][Full Text] [Related]
55. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
56. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses.
Shiohara T; Inaoka M; Kano Y
Allergol Int; 2006 Mar; 55(1):1-8. PubMed ID: 17075280
[TBL] [Abstract][Full Text] [Related]
57. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
Kano Y; Shiohara T
Immunol Allergy Clin North Am; 2009 Aug; 29(3):481-501. PubMed ID: 19563993
[TBL] [Abstract][Full Text] [Related]
58. Up-regulation of Human Herpesvirus 6B-derived microRNAs in the Serum of Patients with Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
Miyashita K; Miyagawa F; Nakamura Y; Ommori R; Azukizawa H; Asada H
Acta Derm Venereol; 2018 Jun; 98(6):612-613. PubMed ID: 29542806
[No Abstract] [Full Text] [Related]
59. Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome.
Nakamura-Nishimura Y; Miyagawa F; Miyashita K; Ommori R; Azukizawa H; Asada H
Br J Dermatol; 2018 Jun; 178(6):1430-1432. PubMed ID: 29150836
[No Abstract] [Full Text] [Related]
60. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management.
Shiohara T; Kano Y
Expert Opin Drug Saf; 2017 Feb; 16(2):139-147. PubMed ID: 27936971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
